The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart Review

作者: Chetan P. Phadke , Caitlin Davidson , Farooq Ismail , Chris Boulias

DOI: 10.1016/J.PMRJ.2013.11.001

关键词:

摘要: Background It is difficult to compare the dosage of botulinum toxin between different neurologic conditions because methods reported dosages. Botulinum used manage spasticity in variety conditions, and it important for clinicians know whether there are differences injected on basis etiology spasticity. Objective To determine type neural lesion influences required Design Retrospective chart review. Setting Review patients who visited an outpatient clinic. Participants We assessed medical charts from 99 with stroke, multiple sclerosis (MS), cerebral palsy (CP) (n = 33 each etiology). collected information such as age, gender, weight, time lesion, total (per person, per limb, muscle), injection location, injections cycles. Interventions None. Main Outcome Measurements OnabotulinumtoxinA dose – one leg was calculated a sum units all muscles. Results Total 161 ± 19 (mean standard error mean) 175 13 CP, 225 18 MS. The legs (normalized body weight; units/kg) significantly 3 groups (stroke, MS; P  = .001). Subsequent post-hoc tests revealed that MS greater (88%) than stroke ( Hip adductors hamstrings were most commonly but toe muscles whereas plantar flexors evenly patient groups. Conclusion In our practice, we found treating people greatest toxin, followed by CP then stroke.

参考文章(30)
April Saval, Anthony E. Chiodo, Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin. Journal of Spinal Cord Medicine. ,vol. 33, pp. 16- 21 ,(2010) , 10.1080/10790268.2010.11689670
M. Barnes, A. Schnitzler, L. Medeiros, M. Aguilar, A. Lehnert-Batar, P. Minnasch, Efficacy and safety of NT 201 for upper limb spasticity of various etiologies – a randomized parallel‐group study Acta Neurologica Scandinavica. ,vol. 122, pp. 295- 302 ,(2010) , 10.1111/J.1600-0404.2010.01354.X
G. Sheean, N. A. Lannin, L. Turner-Stokes, B. Rawicki, B. J. Snow, Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. European Journal of Neurology. ,vol. 17, pp. 74- 93 ,(2010) , 10.1111/J.1468-1331.2010.03129.X
Chetan P. Phadke, Arzu Y. On, Yesim Kirazli, Farooq Ismail, Chris Boulias, Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper. Neuroscience Letters. ,vol. 541, pp. 20- 23 ,(2013) , 10.1016/J.NEULET.2013.02.025
B. Mohammadi, S. Abdoulrahmani Balouch, R. Dengler, K. Kollewe, Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients Neurological Research. ,vol. 32, pp. 309- 313 ,(2010) , 10.1179/016164109X12478302362734
LAURA L TOSI, NANCY MAHER, D WINSLOW MOORE, MURRAY GOLDSTEIN, MINDY L AISEN, Adults with cerebral palsy: a workshop to define the challenges of treating and preventing secondary musculoskeletal and neuromuscular complications in this rapidly growing population Developmental Medicine & Child Neurology. ,vol. 51, pp. 2- 11 ,(2009) , 10.1111/J.1469-8749.2009.03462.X
Barry J. Snow, Joseph K. C. Tsui, Mohit H. Bhatt, Michael Varelas, Stanley A. Hashimoto, Donald B. Calne, Treatment of spasticity with botulinum toxin: a double-blind study. Annals of Neurology. ,vol. 28, pp. 512- 515 ,(1990) , 10.1002/ANA.410280407
Wolfgang H. Jost, Botulinum toxin in multiple sclerosis Journal of Neurology. ,vol. 253, ,(2006) , 10.1007/S00415-006-1104-0
G. Laurent, F. Valentini, K. Loiseau, D. Hennebelle, G. Robain, Claw toes in hemiplegic patients after stroke Annals of Physical and Rehabilitation Medicine. ,vol. 53, pp. 77- 85 ,(2010) , 10.1016/J.REHAB.2009.12.005
Alberto Esquenazi, Nathaniel Mayer, Stella Lee, Allison Brashear, Elie Elovic, Gerard E Francisco, Stuart Yablon, PROS Study Group, Patient Registry of Outcomes in Spasticity Care American Journal of Physical Medicine & Rehabilitation. ,vol. 91, pp. 729- 746 ,(2012) , 10.1097/PHM.0B013E31824FA9CA